We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Morpholino Antisense Library Available

By Biotechdaily staff writers
Posted on 27 Apr 2004
A library of morpholino antisense nucleotides is now commercially available for researchers working with the popular zebrafish development model.

Morpholino oligonucleotides are nonionic DNA analogs that were developed by Gene Tools, LLC (Philomath, OR, USA; www.gene-tools.com). More...
They possess altered backbone linkages compared with DNA or RNA. In spite of their altered backbone, morpholinos bind to complementary nucleic acid sequences by Watson-Crick base-pairing. This binding is no tighter than binding of analogous DNA and RNA oligomers, necessitating the use of relatively long 25-base morpholinos for antisense gene inhibition. The backbone makes morpholinos resistant to digestion by nucleases. Also, because the backbone lacks negative charge, it is thought that morpholinos are less likely to interact nonselectively with cellular proteins. Such interactions often obscure the observation of informative phenotypes.

Morpholinos employ a steric block mechanism (RNAse H-independent) and with their high mRNA binding affinity and specificity, they yield reliable and predictable results. They either can block the translation initiation complex (by targeting the 5' untranslated region through the first 25 bases of coding sequence) or they can block the nuclear splicing machinery (by targeting splice junctions in pre-mRNA). Microinjection or electroporation of morpholino oligos into zebrafish embryos specifically shuts down the expression of targeted genes.

Gene Tools' Expression Arrest Zebrafish Morpholino Library is available to the research community through an exclusive marketing arrangement with Open Biosystems (Huntsville, AL, USA).

Dr. Paul Morcos, director of biology at Gene Tools, said, "The excitement in the gene knockdown field is reaching new heights and this partnership lowers the barrier to entry by enabling laboratories to expand their screening efforts. Morpholinos are the most reliable gene knockdown technology on the market and now the most affordable.”

Gene Tools, LLC >> www.gene-tools.com
Open Biosystems >> www.openbiosystems.com

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.